NOMALEX financials
A multi-period view of the public annual-account figures reported for NOMALEX, with comparable measures and links to available source documents.
Company overviewRegistry number
0649434497
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 28, 2026
Financial evidence
Latest movements for NOMALEX
2025 versus 2024
- Operating line
- €120,829
- EBITDA
- €120,429
- Total assets
- €816,951
- Equity
- €227,617
-5%
-5%
+6%
+25.2%
EBITDA margin +99.7% · Equity ratio +27.9%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €120,829 | €120,429 | €816,951 | €227,617 | - |
| 202431 Dec 2024 | €127,158 | €126,770 | €771,030 | €181,803 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.